Department of Laboratory Medicine, West China Second University Hospital, and Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, Sichuan University, No. 20, Section 3, Renmin South Road, Chengdu, 610041, Sichuan, People's Republic of China.
Virol J. 2023 Sep 3;20(1):202. doi: 10.1186/s12985-023-02169-x.
This study aims to investigate molecular epidemiology and clinical characteristics of enterovirus associated hand-foot-mouth disease (HFMD) in Chengdu, China, 2013-2022. Monitoring the molecular epidemiology and clinical features of HFMD for up to 10 years may provide some ideas for future protection and control measures.
We conducted a retrospective analysis of the medical records of all patients with laboratory-confirmed HFMD-related enterovirus infection at the West China Second University Hospital from January 2013 to December 2022. We described the characteristics in serotype, age, sex distribution and hospitalization of enterovirus infection cases using data analysis and graphic description.
A total of 29,861 laboratory-confirmed cases of HFMD-related enterovirus infection were reported from 2013 to 2022. There was a significant reduction in the number and proportion of EV-A71 cases after 2016, from 1713 cases (13.60%) in 2013-2015 to 150 cases (1.83%) in 2017-2019. During the COVID-19 pandemic, EV-A71 cases even disappeared. The proportion of CV-A16 cases decreased from 13.96% in 2013-2015 to 10.84% in 2017-2019 and then to 4.54% in 2020-2022. Other (non-EV-A71 and non-CV-A16) serotypes accounted for 95.45% during 2020-2022, with CV-A6 accounting for 50.39% and CV-A10 accounting for 10.81%. Thus, CV-A6 and CV-A10 became the main prevalent serotypes. Furthermore, There was no significant difference in the enterovirus prevalence rate between males and females. The hospitalization rate of EV-A71 patients was higher that of other serotypes. In general, the proportion of HFMD hospitalizations caused by other pathogens except for EV-A71, CV-A16, CV-A10 and CV-A16 was second only to that caused by EV-A71. The proportion of children over 4 years old infected with enterovirus increased.
The incidence of HFMD associated with enterovirus infection has decreased significantly and CV-A6 has been the main pathogen of HFMD in Chengdu area in recent years. The potential for additional hospitalizations for other untested enterovirus serotypes suggested that attention should also be paid to the harms of infections with unknown enterovirus serotypes. Children with HFMD were older. The development of new diagnostic reagents and vaccines may play an important role in the prevention and control of enterovirus infection.
本研究旨在调查中国成都 2013-2022 年肠病毒相关手足口病(HFMD)的分子流行病学和临床特征。对 HFMD 进行长达 10 年的分子流行病学和临床特征监测,可为未来的保护和控制措施提供一些思路。
我们对 2013 年 1 月至 2022 年 12 月期间华西第二医院实验室确诊的与 HFMD 相关的肠道病毒感染患者的病历进行了回顾性分析。我们使用数据分析和图形描述描述了血清型、年龄、性别分布和住院情况的特征。
2013 年至 2022 年共报告了 29861 例实验室确诊的 HFMD 相关肠道病毒感染病例。2016 年后,EV-A71 病例数量和比例明显下降,从 2013-2015 年的 1713 例(13.60%)降至 2017-2019 年的 150 例(1.83%)。在 COVID-19 大流行期间,EV-A71 病例甚至消失了。CV-A16 病例的比例从 2013-2015 年的 13.96%下降到 2017-2019 年的 10.84%,然后在 2020-2022 年下降到 4.54%。其他(非 EV-A71 和非 CV-A16)血清型在 2020-2022 年期间占 95.45%,其中 CV-A6 占 50.39%,CV-A10 占 10.81%。因此,CV-A6 和 CV-A10 成为主要流行血清型。此外,男性和女性肠道病毒的流行率没有显著差异。EV-A71 患者的住院率高于其他血清型。一般来说,除 EV-A71、CV-A16、CV-A10 和 CV-A16 以外的其他病原体引起的 HFMD 住院率仅次于 EV-A71。感染肠道病毒的 4 岁以上儿童比例增加。
肠病毒感染引起的 HFMD 发病率显著下降,CV-A6 已成为成都地区近年来 HFMD 的主要病原体。其他未检测到的肠道病毒血清型可能导致更多住院的可能性表明,也应关注未知肠道病毒血清型感染的危害。HFMD 患儿年龄较大。新型诊断试剂和疫苗的开发可能在肠道病毒感染的预防和控制中发挥重要作用。